| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c61be67574606d8e79ede96955b3a7f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-147 |
| filingDate |
2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92c5108a09d769c3154219b8ed1c9a10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ac569ab90f2183fd45ebcc17a30a8d |
| publicationDate |
2022-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114126641-A |
| titleOfInvention |
Composition for preventing or treating obesity comprising phospholipase A2 as active ingredient |
| abstract |
The present invention relates to a composition for improving obesity using phospholipase A2, one of the main components of bee venom, as an active ingredient, and more particularly to: a composition for preventing obesity comprising phospholipase A2 as an active ingredient Or a pharmaceutical composition for treating obesity; a functional healthy food composition for preventing or improving obesity comprising phospholipase A2 as an active ingredient; a feed composition; a method for preventing or treating obesity, The method includes the steps of administering to an individual a composition comprising phospholipase A2 as an active ingredient; and use of the composition comprising phospholipase A2 as an active ingredient for preventing or treating obesity. The composition for reducing inflammatory macrophages and for preventing or treating obesity comprising phospholipase A2, which is the substance of the present invention and the main component of bee venom, as active ingredients, can be effectively used as a pharmaceutical composition. |
| priorityDate |
2019-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |